Homoeopathy In The Management Of Migraine In Women Of Reproductive Age Group: A Review Of Studies

Abstract

Purpose: Migraine is a highly prevalent and disabling neurological condition affecting women of reproductive age (18–45 years) due to hormonal fluctuations, psychosocial stress, and lifestyle factors, which act as triggers for migraine. Conventional pharmacological therapies, while effective for some, may have adverse effects and contraindications during pregnancy. This review critically evaluates the evidence for homoeopathy as a therapeutic option for the management of migraine and associated complaints, particularly in females of the reproductive age group.

Methodology: Literature search was conducted across databases such as PubMed, Scopus, AYUSH Research Portals, Cochrane Library, and Google Scholar and other indexed journals for studies involving migraine and homoeopathic intervention.

Results: A total of 15 studies were identified that had major participants in the desired demographic focus. Studies included randomized controlled trials, observational studies, case reports, and systematic reviews. The collective findings indicate that individualized homoeopathic treatments demonstrated a trend of clinical improvement in migraine symptoms, notably in reducing the attack frequency, intensity, and duration. Trials also reported statistically significant outcomes, and observational data support the long-term benefits of homoeopathic intervention and enhanced quality of life. Case reports further illustrated the potential of an individualised homoeopathic approach in complex or hormonally influenced migraine presentation.

Conclusion: Findings of studies suggest that homoeopathy may offer an individualised and viable utility in the management of migraine in females of the reproductive age group. However, interpretation of results should be done cautiously due to limited long-term data, small sample sizes and heterogeneity in study designs. To further validate these findings, extensive and multicenter RCTs are required, along with more standardized protocols and extended follow-up periods.